Neuroendokrin daganatok: vizsgálatok itt: Franciaország
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Le Kremlin-Bicêtre, Lyon, Marseille, Paris, Strasbourg, Villejuif
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - No phaseTaking peopleClinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
- Where
- Bordeaux, Marseille, Montpellier, Toulouse
- Életkor
- 18 év and over
- People
- 350
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04104529 - 1/2. fázisNot yet taking people in FranciaországDAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Lyon, Marseille, Villejuif
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00 - No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- Clichy
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Clichy, Dijon, Lyon Cedex 03, Marseille, Pessac, Rennes Cedex, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Caen, Clichy, Lille, Lyon, Marseille, Montpellier, Nantes, Rennes, Strasbourg, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - No phaseNot yet taking people in FranciaországReal World Positioning of Tyrosine Kinase Inhibitors (TKIs) Within Systemic Treatment Strategies for Advanced Neuroendocrine Tumors (NETs)
- Where
- Angers, Caen, Clichy, Dijon, La Tronche, Lille, Lyon, Nantes, Paris, Pessac, Poitiers, Reims, Strasbourg, Tours, Villejuif
- Életkor
- 18 év and over
- People
- 100
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07890012 - 1. fázisNot yet taking people in FranciaországPhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Lyon, Marseille, Toulouse Cedex 9
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 3. fázisTaking peopleRandomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
- Where
- Caen, Clichy, Dijon, Lille, Lyon, Marseille, Paris, Rennes, Villejuif
- Életkor
- 18 év and over
- People
- 166 worldwide
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT06878664 · EU 2024-517921-14-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Bordeaux, Bron, Clichy, Lyon Cedex 03, Marseille, Montpellier Cedex 5, Nantes, Pessac, Pierre-Bénite, Talence, Toulouse
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - 2. fázisTaking peopleFIRST-NEC - A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab (MEDI 4736) with etoposide and platinum as first line treatment in patients with large-cell neuroendocrine carcinomas (LCNECs) of the lung.
- Where
- Aix En Provence, Amiens Cedex 1, Brest Cedex 2, Caen Cedex 5, Créteil, Grenoble Cedex 9, Lille, Limoges Cedex 1, Lorient, Lyon, Lyon Cedex 02, Marseille, Meaux, Mulhouse, Nice, Paris, Paris Cedex 20, Pringy Cedex, Quimper Cedex, Rennes, Strasbourg, Strasbourg Cedex, Toulon Cedex 9, Villefranche Sur Saone Cedex
- Életkor
- 18 év and over
- People
- 80
- Run by
- Centre Leon Berard
See details and how to join2023-506590-35-00 - No phaseTaking peopleSuperb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy
- Where
- Lyon
- Életkor
- 18 év and over
- People
- 150
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07274657 - 3. fázisFut, nem toborozStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Creteil Cedex, Lyon, Marseille, Paris, Rouen Cedex, Saint-Herblain, Toulon Cedex 9, Toulouse
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 - No phaseTaking peopleTARGETed Therapy Drug MONITOring in DIGestive Oncology
- Where
- Amiens, Auxerre, Avignon, Bayeux, Clermont-Ferrand, Clichy, Dijon, Évreux, Lille, Lyon, Marseille, Nancy, Nantes, Nice, Paris, Plérin, Poitiers, Reims, Rennes, Rouen, St-Malo, Strasbourg, Tours, Villejuif
- Életkor
- 18 év and over
- People
- 330
- Run by
- UNICANCER
See details and how to joinNCT05443087 - 2. fázisBefejeződöttDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Créteil, Marseille, Paris, Strasbourg Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseTaking peopleEvaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour
- Where
- Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Nantes, Poitiers, Toulouse
- Életkor
- 18 év and over
- People
- 150
- Run by
- Institut Claudius Regaud
See details and how to joinNCT06876532 - 1/2. fázisNot yet taking people in FranciaországA Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Where
- Marseille, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 262 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07174583 · EU 2025-523438-24-00 - 2. fázisTaking peopleAssessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET
- Where
- Angers, Bordeaux, Brest, Caen Cedex 5, Chambéry, Clermont-Ferrand, Clichy, Dijon, Grenoble Cedex 9, Lille Cedex, Lyon, Lyon Cedex 02, Marseille, Montpellier Cedex 5, Nantes, Nice Cedex 2, Paris, Paris Cedex 13, Pessac, Rouen, Rouen Cedex, St Etienne Cedex 2, St Herblain, Strasbourg Cedex, Toulouse, Vandoeuvre Les Nancy Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 146
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04954820 · EU 2024-511001-28-00 - No phaseTaking peopleStudy of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
- Where
- Dijon
- Életkor
- 18 év to 60 év
- People
- 297
- Run by
- Centre Hospitalier Universitaire Dijon
See details and how to joinNCT06430021 - 3. fázisNot yet taking people in FranciaországAdjuvant Trial in Pancreatic Neuroendocrine Tumors
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 300
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07591493 - 1/2. fázisFelfüggesztveStudy Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
- Where
- Clichy, Nantes Cedex 1
- Életkor
- 18 év and over
- People
- 60
- Run by
- Nantes University Hospital
See details and how to joinNCT06735560 · EU 2023-508567-75-00 - 3. fázisTaking peopleEfficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Where
- Bourdeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00 - 2. fázisTaking peopleAssessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
- Where
- Amiens, Caen, Lille
- Életkor
- 18 év and over
- People
- 88
- Run by
- Centre Oscar Lambret
See details and how to joinNCT05500391 - No phaseNot yet taking people in FranciaországSurvival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor
- Where
- Caen, Clermont-Ferrand, Clichy, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Reims, Rennes, Strasbourg, Toulouse, Tours
- Életkor
- 18 év and over
- People
- 1100
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07471425